Heightened Standards Proposed For Finger-Prick Devices
This article was originally published in The Gray Sheet
Executive Summary
FDA issued proposed orders to remove the 510(k) exemption and establish special controls for most blood lancets, and require PMAs for one super-risky category of the finger-prick devices. The goal is to reduce infectious disease transmission.
You may also be interested in...
FDA To Impose Premarket Requirements On Blood Lancets
Single-patient lancets will face new special controls and 510(k) submission, while multiple-patient lancets would require a PMA.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.